The interaction of the glymphatic system with various neurodegenerative mechanisms suggests AQP‐4 as a promising target for research and therapeutic interventions in PD, warranting further investigation into its role in neuroinflammation and glymphatic dysfunction [45]. The gene discussed is AQP4; the disease is Parkinson disease.